🟢 Tenax Therapeutics is trading 5% up today as XBI gains 2.55%

Tenax Therapeutics is trading at $1.95, up 5.01% amid biotech-sector strength, with XBI up 2.55% and outperforming the broader market on September 18, 2026.

• Recent insider buying may support sentiment: the CFO purchased 5,675 shares for $10,981 on September 11.
• The purchase followed mixed LEVEL trial results and analyst reactions; no new company-specific announcement was identified for September 18.